Clinical outcomes of suboptimal stent deployment as assessed by optical coherence tomography: long-term results of the CLI-OPCI registry.


Journal

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
ISSN: 1969-6213
Titre abrégé: EuroIntervention
Pays: France
ID NLM: 101251040

Informations de publication

Date de publication:
03 Jun 2022
Historique:
pubmed: 27 11 2021
medline: 7 6 2022
entrez: 26 11 2021
Statut: epublish

Résumé

Intraprocedural optical coherence tomography (OCT) is a valuable tool for guidance of percutaneous coronary intervention, but long-term follow-up data are lacking. The aim of this study was to address the long-term (7.5 years) clinical impact of quantitative OCT metrics of suboptimal stent implantation. This retrospective study includes 391 patients with long-term follow-up (mean 2,737 days; interquartile range 1,301-3,143 days) from the multicentre Centro per la Lotta contro l'Infarto - Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) registry. OCT-assessed suboptimal stent deployment required the presence of at least one of the following pre-defined OCT findings: in-stent MLA <4.5 mm One hundred and two patients (26.1%) with 138 stented lesions (27.7%) experienced a device-oriented cardiovascular event (DOCE). In-stent MLA <4.5 mm The presence of OCT-assessed suboptimal criteria for stent implantation was related to a worse clinical outcome at very long-term follow-up. This information further supports an OCT-guided strategy of stent deployment.

Sections du résumé

BACKGROUND BACKGROUND
Intraprocedural optical coherence tomography (OCT) is a valuable tool for guidance of percutaneous coronary intervention, but long-term follow-up data are lacking.
AIMS OBJECTIVE
The aim of this study was to address the long-term (7.5 years) clinical impact of quantitative OCT metrics of suboptimal stent implantation.
METHODS METHODS
This retrospective study includes 391 patients with long-term follow-up (mean 2,737 days; interquartile range 1,301-3,143 days) from the multicentre Centro per la Lotta contro l'Infarto - Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) registry. OCT-assessed suboptimal stent deployment required the presence of at least one of the following pre-defined OCT findings: in-stent MLA <4.5 mm
RESULTS RESULTS
One hundred and two patients (26.1%) with 138 stented lesions (27.7%) experienced a device-oriented cardiovascular event (DOCE). In-stent MLA <4.5 mm
CONCLUSIONS CONCLUSIONS
The presence of OCT-assessed suboptimal criteria for stent implantation was related to a worse clinical outcome at very long-term follow-up. This information further supports an OCT-guided strategy of stent deployment.

Identifiants

pubmed: 34825652
pii: EIJ-D-21-00627
doi: 10.4244/EIJ-D-21-00627
pmc: PMC9904373
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e150-e157

Références

J Am Coll Cardiol. 2014 Jul 15;64(2):207-22
pubmed: 24530669
J Am Coll Cardiol. 2002 Feb 20;39(4):604-9
pubmed: 11849858
JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75
pubmed: 20129555
Circulation. 2016 Sep 27;134(13):906-17
pubmed: 27573032
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
pubmed: 22421299
Circulation. 2007 May 1;115(17):2344-51
pubmed: 17470709
EuroIntervention. 2020 Aug 07;16(6):e480-e488
pubmed: 31829943
Eur Heart J. 2006 Jun;27(11):1305-10
pubmed: 16682378
EuroIntervention. 2021 Jan 20;16(13):1092-1099
pubmed: 32863246
Am Heart J. 2001 May;141(5):823-31
pubmed: 11320373
EuroIntervention. 2018 Jul 20;14(4):e443-e451
pubmed: 29633940
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1313-1321
pubmed: 30025725
Eur Heart J. 2018 Sep 14;39(35):3281-3300
pubmed: 29790954
Lancet. 2016 Nov 26;388(10060):2618-2628
pubmed: 27806900
J Am Coll Cardiol. 2004 Jun 2;43(11):1959-63
pubmed: 15172398
Circ Cardiovasc Interv. 2016 Dec;9(12):
pubmed: 27965297
JACC Cardiovasc Interv. 2015 Nov;8(13):1704-14
pubmed: 26585621
Circulation. 2015 Sep 15;132(11):1020-9
pubmed: 26162917
JACC Cardiovasc Imaging. 2015 Nov;8(11):1297-305
pubmed: 26563859
Eur Heart J. 2012 Oct;33(20):2513-20
pubmed: 22653335
J Am Heart Assoc. 2016 Dec 22;5(12):
pubmed: 28007741
Catheter Cardiovasc Interv. 2014 May 1;83(6):873-8
pubmed: 22815193
Eur Heart J. 2012 Oct;33(20):2551-67
pubmed: 22922414
EuroIntervention. 2012 Nov 22;8(7):823-9
pubmed: 23034247
JACC Cardiovasc Imaging. 2017 Dec;10(12):1487-1503
pubmed: 29216976

Auteurs

Francesco Prati (F)

Cardiovascular Sciences Department, San Giovanni Addolorata Hospital, Rome, Italy.
UniCamillus - Saint Camillus International University of Health Sciences, Rome, Italy.
Centro per la Lotta Contro L'Infarto - CLI Foundation, Rome, Italy.

Enrico Romagnoli (E)

Centro per la Lotta Contro L'Infarto - CLI Foundation, Rome, Italy.
Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Flavio Giuseppe Biccirè (FG)

Cardiovascular Sciences Department, San Giovanni Addolorata Hospital, Rome, Italy.
Centro per la Lotta Contro L'Infarto - CLI Foundation, Rome, Italy.
Sapienza University of Rome, Rome, Italy.

Francesco Burzotta (F)

Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Alessio La Manna (A)

Cardio-Thoracic-Vascular Department, Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy.

Simone Budassi (S)

Cardiovascular Sciences Department, San Giovanni Addolorata Hospital, Rome, Italy.
Centro per la Lotta Contro L'Infarto - CLI Foundation, Rome, Italy.

Vito Ramazzotti (V)

Cardiovascular Sciences Department, San Giovanni Addolorata Hospital, Rome, Italy.

Mario Albertucci (M)

Cardiovascular Sciences Department, San Giovanni Addolorata Hospital, Rome, Italy.
Centro per la Lotta Contro L'Infarto - CLI Foundation, Rome, Italy.

Franco Fabbiocchi (F)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Alessandro Sticchi (A)

UniCamillus - Saint Camillus International University of Health Sciences, Rome, Italy.
Centro per la Lotta Contro L'Infarto - CLI Foundation, Rome, Italy.

Carlo Trani (C)

Department of Cardiovascular and Thoracic Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Giuseppe Calligaris (G)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Massimo Fineschi (M)

Azienda Ospedaliera Universitaria Senese, Siena, Italy.

Francesco Versaci (F)

Cardiology Department, Santa Maria Goretti Hospital, Latina, Italy.

Corrado Tamburino (C)

Cardio-Thoracic-Vascular Department, Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy.

Yukio Ozaki (Y)

Department of Cardiology, Fujita Health University Hospital, Toyoake, Japan.

Fernando Alfonso (F)

Department of Cardiology, Hospital Universitario de La Princesa, Universidad Autónoma Madrid, CIBERCV, Madrid, Spain.

Gary S Mintz (GS)

Cardiovascular Research Foundation, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH